Metformin as Targeted Treatment in Fragile X Syndrome
Background Individuals with fragile X syndrome (FXS) have both behavioral and medical comorbidities and the latter include obesity in approximately 30% and the Prader‐Willi Phenotype (PWP) characterized by severe hyperphagia and morbid obesity in less than 10%. Metformin is a drug used in individual...
Saved in:
Main Authors: | Dy, Angel Belle C, Tassone, F, Eldeeb, M, Salcedo-Arellano, M.J, Tartaglia, N, Hagerman, R |
---|---|
格式: | text |
出版: |
Archīum Ateneo
2017
|
主題: | |
在線閱讀: | https://archium.ateneo.edu/asmph-pubs/23 https://onlinelibrary.wiley.com/doi/full/10.1111/cge.13039 |
標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|
相似書籍
-
Fragile X- associated Neuropsychiatric Disorders: A Case Report
由: Tan, Maria Melinda, et al.
出版: (2019) -
New Targeted Treatments for Fragile X Syndrome
由: Protic, Dragana, et al.
出版: (2019) -
A case of Noonan syndrome associated with nephrotic syndrome, pituitary mass and pes varus
由: Pacheco, Elizabeth Paz-, et al.
出版: (2013) -
Autism Symptoms in Fragile X Syndrome
由: Niu, Manman, et al.
出版: (2017) -
Maternal and neonatal service usage and determinants in fragile and conflict-affected situations: a systematic review of Asia and the Middle-East
由: Gopalan, Saji S, et al.
出版: (2021)